These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 29022427)

  • 1. Confirming the timing of phase-based costing in oncology studies: a case example in advanced melanoma.
    Atkins M; Coutinho AD; Nunna S; Gupte-Singh K; Eaddy M
    J Med Econ; 2018 Feb; 21(2):212-217. PubMed ID: 29022427
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Estimation of Direct Melanoma-related Costs by Disease Stage and by Phase of Diagnosis and Treatment According to Clinical Guidelines.
    Buja A; Sartor G; Scioni M; Vecchiato A; Bolzan M; Rebba V; Sileni VC; Palozzo AC; Montesco M; Del Fiore P; Baldo V; Rossi CR
    Acta Derm Venereol; 2018 Feb; 98(2):218-224. PubMed ID: 29110018
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Melanoma costs: a dynamic model comparing estimated overall costs of various clinical stages.
    Alexandrescu DT
    Dermatol Online J; 2009 Nov; 15(11):1. PubMed ID: 19951637
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Direct economic burden of high-risk and metastatic melanoma in the elderly: evidence from the SEER-Medicare linked database.
    Davis KL; Mitra D; Kotapati S; Ibrahim R; Wolchok JD
    Appl Health Econ Health Policy; 2009; 7(1):31-41. PubMed ID: 19558193
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The burden of metastatic melanoma: treatment patterns, healthcare use (utilization), and costs.
    Reyes C; DaCosta Byfield S; Linke R; Satram-Hoang S; Teitelbaum AH
    Melanoma Res; 2013 Apr; 23(2):159-66. PubMed ID: 23370422
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Economic impact of healthcare resource utilisation patterns among patients diagnosed with advanced melanoma in the United Kingdom, Italy, and France: results from a retrospective, longitudinal survey (MELODY study).
    Johnston K; Levy AR; Lorigan P; Maio M; Lebbe C; Middleton M; Testori A; Bédane C; Konto C; Dueymes A; Sbarigia U; van Baardewijk M
    Eur J Cancer; 2012 Sep; 48(14):2175-82. PubMed ID: 22480965
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Healthcare costs in patients with advanced non-small cell lung cancer and disease progression during targeted therapy: a real-world observational study.
    Skinner KE; Fernandes AW; Walker MS; Pavilack M; VanderWalde A
    J Med Econ; 2018 Feb; 21(2):192-200. PubMed ID: 29041833
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The economic burden of end-of-life care in metastatic breast cancer.
    Bramley T; Antao V; Lunacsek O; Hennenfent K; Masaquel A
    J Med Econ; 2016 Nov; 19(11):1075-1080. PubMed ID: 27248201
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Economic burden of melanoma in the elderly population: population-based analysis of the Surveillance, Epidemiology, and End Results (SEER)--Medicare data.
    Seidler AM; Pennie ML; Veledar E; Culler SD; Chen SC
    Arch Dermatol; 2010 Mar; 146(3):249-56. PubMed ID: 20231494
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Estimating healthcare resource use associated with the treatment of metastatic melanoma in eight countries.
    McKendrick J; Gijsen M; Quinn C; Barber B; Zhao Z
    J Med Econ; 2016 Jun; 19(6):587-95. PubMed ID: 26823114
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Melanoma treatment costs: a systematic review of the literature, 1990-2011.
    Guy GP; Ekwueme DU; Tangka FK; Richardson LC
    Am J Prev Med; 2012 Nov; 43(5):537-45. PubMed ID: 23079178
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The economic burden of lung cancer and the associated costs of treatment failure in the United States.
    Kutikova L; Bowman L; Chang S; Long SR; Obasaju C; Crown WH
    Lung Cancer; 2005 Nov; 50(2):143-54. PubMed ID: 16112249
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Health Care Resource Utilization and Associated Costs Among Metastatic Cutaneous Melanoma Patients Treated with Ipilimumab (INTUITION Study).
    McArthur GA; Mohr P; Ascierto PA; Arance A; Banos Hernaez A; Kaskel P; Weichenthal M; Shinde R; Stevinson K
    Oncologist; 2017 Aug; 22(8):951-962. PubMed ID: 28526721
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Economic burden of brain metastases among patients with metastatic melanoma in a USA managed care population.
    Vekeman F; Cloutier M; Yermakov S; Amonkar MM; Arondekar B; Duh MS
    Melanoma Res; 2014 Dec; 24(6):602-10. PubMed ID: 24926818
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An estimate of the annual direct cost of treating cutaneous melanoma.
    Tsao H; Rogers GS; Sober AJ
    J Am Acad Dermatol; 1998 May; 38(5 Pt 1):669-80. PubMed ID: 9591809
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Burden and treatment patterns of advanced basal cell carcinoma among commercially insured patients in a United States database from 2010 to 2014.
    Migden M; Xie J; Wei J; Tang W; Herrera V; Palmer JB
    J Am Acad Dermatol; 2017 Jul; 77(1):55-62.e3. PubMed ID: 28392293
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Is sex an independent prognostic factor in cutaneous head and neck melanoma?
    Arce PM; Camilon PR; Stokes WA; Nguyen SA; Lentsch EJ
    Laryngoscope; 2014 Jun; 124(6):1363-7. PubMed ID: 24122966
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An estimate of the cost of treating melanoma disease in the state of Sao Paulo - Brazil.
    Souza RJ; Mattedi AP; Rezende ML; Corrêa Mde P; Duarte EM
    An Bras Dermatol; 2009 Jul; 84(3):237-43. PubMed ID: 19668936
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nail apparatus melanoma: A comparative, clinicoprognostic study of the initial clinical and morphological characteristics of 49 patients.
    Lee WJ; Lee JH; Won CH; Chang SE; Choi JH; Moon KC; Lee MW
    J Am Acad Dermatol; 2015 Aug; 73(2):213-20. PubMed ID: 26028523
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The economic burden of melanoma in France: assessing healthcare use in a hospital setting.
    Chevalier J; Bonastre J; Avril MF
    Melanoma Res; 2008 Feb; 18(1):40-6. PubMed ID: 18227707
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.